Feng SS. Nanoparticles of biodegradable polymers for new concept chemotherapy

Department of Chemical and Biomolecular Engineering, Faculty of Engineering, National University of Singapore, 10 Kent Ridge Crescent, Singapore 119260.
Expert Review of Medical Devices (Impact Factor: 1.78). 10/2004; 1(1):115-25. DOI: 10.1586/17434440.1.1.115
Source: PubMed

ABSTRACT The current regimen of chemotherapy is far from satisfactory--its efficiency is limited and patients suffer from serious side effects. Various drug delivery devices have been under intensive investigation in the past few decades in attempts to develop controlled and targeted methods of chemotherapy administration. This article reviews the latest developments in nanoparticles of biodegradable polymers for chemotherapy of cancer and other diseases such as cardiovascular restenosis. The preliminary results obtained in the author's laboratory are used to demonstrate the concept. This review is written with the belief that engineering, in particular, chemical engineering principles, can be applied and further developed to solve the problems in the current practice of chemotherapy and promote a new concept of chemotherapy - chemotherapy at home.

  • Source
    • "In engineered nanomaterials, size is a crucial factor that regulates the circulation and navigation of nanomaterials in the bloodstream, penetration across the physiological drug barriers, site-and cell-specific localization and even induction of cellular responses (Feng, 2004; Ferrari, 2008; Jiang et al., 2008). In general, the size of a nonspherical nanomaterial is defined as an equivalent diameter of a spherical particle whose selected physical properties, e.g. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Advances in nanotechnology have opened up a new era of diagnosis, prevention and treatment of diseases and traumatic injuries. Nanomaterials, including those with potential for clinical applications, possess novel physicochemical properties that have an impact on their physiological interactions, from the molecular level to the systemic level. There is a lack of standardized methodologies or regulatory protocols for detection or characterization of nanomaterials. This review summarizes the techniques that are commonly used to study the size, shape, surface properties, composition, purity and stability of nanomaterials, along with their advantages and disadvantages. At present there are no FDA guidelines that have been developed specifically for nanomaterial based formulations for diagnostic or therapeutic use. There is an urgent need for standardized protocols and procedures for the characterization of nanoparticles, especially those that are intended for use as theranostics.
    Biotechnology advances 11/2013; 32(4). DOI:10.1016/j.biotechadv.2013.11.006 · 8.91 Impact Factor
  • Source
    • "In recent years the nanotechnology has created one of the fast growing research fields in the pharmaceutical science [1] [2]. Many scientific groups have focused their research interests in synthesis and characterization of drug delivery formulations with shapes and sizes spanning within the nanometer scale range [3] [4]. The investigators' efforts involve elaboration of new synthetic methods, improvement of the stability of drug carriers, and their drug release properties for better targeting to the recipient cells and tissues [5] [6] [7]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Copolymer (vinyl acetate (VA)-co-3-dimethyl(methacryloyloxyethyl)ammonium propane sulfonate (DMAPS)) nanoparticles have been synthesized by radical copolymerization in water. It was established that the variation of the initial monomer feed (DMAPS concentration was 10 mol% (copolymer 1) and 90 mol% (copolymer 2)) changes the copolymerization type, nanoparticles morphology, self-organization and size distribution. The shape, average diameter, size distribution and zeta potential of the copolymer nanoparticles are determined by atomic force microscopy (AFM), dynamic light scattering and zeta potential data, respectively. While the copolymer 1 nanoparticles are solid with spherical shape, average diameter 276 nm and zeta potential −25.2 mV, the copolymer 2 nanoparticles have bean-like shapes with an average diameter 49.3 nm and zeta potential −4.4 mV and contain many domains with different density. For the first time the AFM images of the copolymer 2 nanoparticles presented the unique self-organization of the dipole–dipole clusters of DMAPS units. The results indicated that the obtained copolymer nanoparticles with specific structure could be used as drug delivery systems.
    European Polymer Journal 03/2013; 49(3):637–645. DOI:10.1016/j.eurpolymj.2012.12.003 · 3.24 Impact Factor
  • Source
    • "These obstacles reinforce the need of an engineered (Yih and Al- Fandi, 2006; Van Vlerken and Amiji, 2006) surface with responsive and biodegradable (Feng, 2004; Panyam and Labhasetwar, 2003) chemical bonds. All of these strategies (Allen and Cullis, 2004) imply the presence of ligands such as peptides (RGD, TAT), sugars (galactose ) or proteins (growth factors, antibodies). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Lipidic NanoCapsules (LNCs) were prepared via an emulsion phase inversion method. Nanoparticles with hydrodynamic diameter of 25, 50 and 100 nm were easily obtained. Their surfaces are covered with short PEG chains (PEG 660) which are not bearing any chemical reactivities. Thus, in order to overcome this handicap towards post-functionalization possibilities, post-insertion of DSPE-PEG2000 amino (DSPA) can be employed. In order to characterize the insertion step, we have developed a chemical assay for the quantification of amino group inside the PEG shell of LNCs. Subsequently, the post-insertion yield was found to be comprised between 60 and 90% whatever the hydrodynamic diameter of the LNCs is. By means of simple calculations, the density of amino group is estimated to be closed to 0.2 and 1.2 molecules/nm(2). The formulation of LNCs and their controlled functionalization represent an interesting system for the development of bionanoconjugates in a short and effective process.
    International Journal of Pharmaceutics 08/2011; 419(1-2):266-70. DOI:10.1016/j.ijpharm.2011.07.028 · 3.65 Impact Factor
Show more